# Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism

> **NCT05493163** · PHASE4 · RECRUITING · sponsor: **Faculty Hospital Kralovske Vinohrady** · enrollment: 558 (estimated)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Thrombolytic
- **DRUG:** Standard anticoagulation

## Key facts

- **NCT ID:** NCT05493163
- **Lead sponsor:** Faculty Hospital Kralovske Vinohrady
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-19
- **Primary completion:** 2026-01
- **Final completion:** 2028-01
- **Target enrollment:** 558 (ESTIMATED)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493163, "Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT05493163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*